Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2960-2966

  Gregory, Christopher W ^a   Wilson, Elizabeth M ^a   Apparao, K B C ^a   Lininger, Ruth A ^a   Meyer, William R ^a   Kowalik, Ania ^a   Fritz, Marc A ^a   Lessey, Bruce A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLIFIED IN BREAST CANCER 1; CLOMIFENE CITRATE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; NUCLEAR RECEPTOR COACTIVATOR 2; PROGESTERONE; PROTEIN P160; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANOVULATION; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE FERTILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0036072430     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8572     Document Type: Article

References (33)

1. Evolution of a model of estrogen action
2. Estrogen and progestin receptors in the reproductive tract of male and female primates
3. Dynamics of steroid hormone receptor action
4. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle
5. Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor
6. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating
7. Polycystic ovary syndrome - From gynaecological curiosity to multisystem endocrinopathy
8. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
9. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
10. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and independent pathways
11. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome
12. Characterization of the androgen receptor in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa)
13. Dating the endometrial biopsy
14. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody
15. Use of integrins to date the endometrium
16. A mechanism for androgen receptor mediated prostate cancer recurrence after androgen deprivation therapy
17. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium
18. The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects
19. Endometrial adenocarcinoma and polycystic ovarian syndrome: Risk factors, management, and prognosis
20. Evidence for expression of estrogen receptor cofactor messenger ribonucleic acid in the ovary and uterus of domesticated animals
21. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium
22. Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells
23. Estrogen receptor cofactors expression in breast and endometrial human cancer cells
24. Cumulative conception rates following gonadotropin therapy
25. Recurrent early miscarriage and polycystic ovaries
26. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle
27. Epidermal growth factor and sex steroids dynamically regulate a marker of endometrial receptivity in Ishikawa cells
28. Endometrial β3 integrin subunit gene expression is mediated by SP1
29. Endometrial estrogen receptor-α expression is increased in women with defects in uterine receptivity: A unifying concept for implantation failure?
30. Differential uterine expression of estrogen and progesterone receptors correlates with uterine preparation for implantation and decidualization in the mouse
31. Expression levels of estrogen receptor-α, estrogen receptor-β, coactivators, and corepressors in breast cancer
32. Altered expression of estrogen receptor co-regulators during human breast tumorigenesis
33. Predictive value of SRC1 for tamoxifen response of recurrent breast cancer